Superficial juvenile granular dystrophy.

Ophthalmology

Department of Ophthalmology, Labbafinejad Medical Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.

Published: January 1992

Seventeen cases of a superficial corneal dystrophy are presented. The lesions are subepithelial, limited mainly to Bowman's layer. This dystrophy, although clinically different from classic granular dystrophy, is pathologically similar to it. Treatment, consisting of superficial keratectomy to 15% to 20% of corneal thickness, did not require lamellar grafting and produced good visual results. A new classification of granular dystrophy is proposed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0161-6420(92)32004-4DOI Listing

Publication Analysis

Top Keywords

granular dystrophy
12
dystrophy
5
superficial juvenile
4
juvenile granular
4
dystrophy seventeen
4
seventeen cases
4
cases superficial
4
superficial corneal
4
corneal dystrophy
4
dystrophy presented
4

Similar Publications

Corneal dystrophies are a group of rare genetic eye disorders characterized by the accumulation of abnormal material in different layers of the cornea, potentially leading to vision impairment. In vivo confocal microscopy (IVCM) is an emerging non-invasive imaging and diagnostic tool that helps study the ocular surface microstructure. This case report examines the clinical characteristics of Avellino corneal dystrophy in a young patient through the use of slit lamp examination, IVCM, and optical coherence tomography (OCT) in order to assess the effectiveness of these non-invasive tests as diagnostic tools.

View Article and Find Full Text PDF

Objective: The pathogenesis of inflammatory myopathies is poorly understood and there is a need to dissect the transcriptome in more granular ways beyond gene expression.

Methods: We used a set of muscle RNA-sequencing data from different myositis subtypes grouped by their specific autoantibodies (n = 152). We quantified annotated RNA transcripts for each myositis subtype and identified uniquely expressed RNA as well as transcriptional similarities among myositis types.

View Article and Find Full Text PDF

Purpose: To report the management of recurrent TGF BI dystrophy after prior femtosecond-assisted anterior lamellar keratoplasty (FALK) with repeat FALK.

Methods: Clinical and histopathological study of 2 eyes of 2 patients with a recurrence of TGFBI dystrophy. Patient 1 had Reis-Buckler corneal dystrophy, and patient 2 had granular corneal dystrophy GCD type 1.

View Article and Find Full Text PDF
Article Synopsis
  • Ritlecitinib, a drug being tested for alopecia areata, caused reversible axonal swelling and auditory potential changes in dogs at doses higher than what's approved for humans.
  • * A phase 2a study evaluated the effects of ritlecitinib on auditory and nerve fiber changes in 71 patients, comparing results with a placebo group over 9 months.
  • * Findings showed no significant differences in auditory or nerve fiber measures between the treatment and placebo groups, suggesting that dog toxicity findings may not apply to human patients.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates a new genetic link between certain variants and congenital glaucoma within a family affected by GAPO syndrome, along with other unrelated cases of juvenile open-angle glaucoma (JOAG) and primary congenital glaucoma (PCG).
  • - Researchers identified three girls with GAPO syndrome from a consanguineous family, two of whom had congenital glaucoma, and discovered a unique mutation in all affected siblings, indicating a potential common genetic factor.
  • - Additional findings revealed rare variants shared among other patients with JOAG and PCG, suggesting the need for further research to understand how these genetic variations may contribute to the development of these glaucomas.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!